Skip to content

MAP Pharmaceuticals, Inc.

-->-->-->-->

Investor Relations

Analyst Coverage

Firm Analyst
Deutsche Bank   David M. Steinberg
Ladenberg Thalmann   Geoffrey O'Brien
Merrill Lynch   Gregg Gilbert
Morgan Stanley   Steven Harr, M.D.

MAP Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding MAP Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MAP Pharmaceuticals, Inc. or its management. MAP Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Stock Information
NASD:MAPP
$9.95  
- 0.50
Aug 28, 2008 1:43 PM ET
Quotes delayed at least 20 minutes.
Information provided by TurboFeed.